Bortezomib in Treating Patients With Myelodysplastic Syndromes

Clinical trial NCT00262873 · COMPLETED

Trial details

NCT number: NCT00262873
Sponsor: University of Rochester
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2005-05-01
Primary completion: 2010-10-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.